Cargando…
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
BACKGROUND: We wished to evaluate the clinical response following ATP-Tumor Chemosensitivity Assay (ATP-TCA) directed salvage chemotherapy in a series of UK patients with advanced ovarian cancer. The results are compared with that of a similar assay used in a different country in terms of evaluabili...
Autores principales: | Sharma, Sanjay, Neale, Michael H, Di Nicolantonio, Federica, Knight, Louise A, Whitehouse, Pauline A, Mercer, Stuart J, Higgins, Bernard R, Lamont, Alan, Osborne, Richard, Hindley, Andrew C, Kurbacher, Christian M, Cree, Ian A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC166157/ https://www.ncbi.nlm.nih.gov/pubmed/12841853 http://dx.doi.org/10.1186/1471-2407-3-19 |
Ejemplares similares
-
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay
por: Knight, Louise A, et al.
Publicado: (2009) -
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours
por: Knight, Louise A, et al.
Publicado: (2004) -
Cancer cell adaptation to chemotherapy
por: Di Nicolantonio, Federica, et al.
Publicado: (2005) -
Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C
por: Whitehouse, P A, et al.
Publicado: (2003) -
Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay
por: Fehm, Tanja, et al.
Publicado: (2012)